04 | 29 | 2005
A Closer Look at The Suicide Risk With Epilepsy Drugs
On April 20, 2005, the FDA declared that manufactures of epilepsy drugs, such as Neurontin and Depakote, need to reexamine their data to see if there is a link between the drugs use and increase in suicide and suicidal behavior.
This is similar to last year's request by the FDA regarding the suicide rate in children and antidepressants known as SSRI's. The FDA placed its sternest warning, the arguably toothless "black box" warning, on the entire class of drugs based on the results of inquiry.
Continue Reading Posted In Neurontin , Pharmaceutical LitigationComments / Questions (0) | Permalink